8-K 1 medicalogic8k040203.txt 8K, MAIN TEXT SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 --------------------------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report April 2, 2003 (Date of earliest event reported) ---------------------------------- MedicaLogic/Medscape, Inc. (Exact name of registrant as specified in charter) Oregon 000-28285 93-0890696 -------------------------------------------------------------------------------- (State or other (Commission file (IRS employer jurisdiction number) identification no.) of incorporation) 20540 NW Evergreen Parkway Hillsboro, Oregon 97124 -------------------------------------------------------------------------------- (Address of principal executive offices) Registrant's telephone number, (503) 531-7000 including area code ----------------------------------- Not applicable -------------------------------------------------------------------------------- (Former name or former address, if changed since last report) Item 5. Other Events On January 24, 2002, MedicaLogic/Medscape, Inc. (the "Company") and its five United States subsidiaries filed a voluntary petition for bankruptcy protection (collectively, the "Bankruptcy Cases") under Chapter 11 of the U.S. Bankruptcy Code (the "Code") in the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court"). The Bankruptcy Cases were assigned to the Honorable Judge Peter J. Walsh and are jointly administered and coordinated under Case Numbers 02-10253 (PJW) through 02-10258 (PJW). In addition to the Company, the filing entities were MSCP Holdings, Inc., MedicaLogic Enterprises, Inc., MedicaLogic Pennsylvania, LLC, MedicaLogic of Texas, Inc. and MedicaLogic Texas, L.P. (collectively, with the Company, the "Debtors"). On November 22, 2002, the Debtors filed a Joint Plan of Liquidation and related Disclosure Statement in the Bankruptcy Court pursuant to the Code. On December 20, 2003, the Debtors filed a First Amended Joint Plan of Liquidation (the "Plan") and related First Amended Disclosure Statement. The Court confirmed the Plan on March 3, 2003. On April 3, 2003, the Debtors filed with the Bankruptcy Court a Notice of (1) Entry of Confirmation Order, (2) Occurrence of Effective Date, and (3) Important Bar Dates announcing, among other things, that the effective date of the Plan occurred on April 2, 2003 (the "Notice"). The Notice is attached hereto as Exhibit 99.1 Item 7. Financial Statements and Exhibits. (c) Exhibits ================================================================================ Exhibit No. Description 99.1 Notice of (1) Entry of Confirmation Order, (2) Occurrence of Effective Date, and (3) Important Bar Dates ================================================================================ SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: April 8, 2003 MEDICALOGIC/MEDSCAPE, INC. By: /s/ Hobart T. Truesdall ----------------------------------- Name: Hobart T. Truesdall Title: Trustee EXHIBIT INDEX ================================================================================ 99.1 Notice of (1) Entry of Confirmation Order, (2) Occurrence of Effective Date, and (3) Important Bar Dates ================================================================================